| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 06/13/1995 | US5424057 Medical diagnosis |
| 06/13/1995 | CA1335892C Saccharide derivatives |
| 06/07/1995 | EP0656002A1 3-oxo-pyrido(1,2-a -)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a -)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders |
| 06/07/1995 | EP0655917A1 Crystalline amifostine compositions and methods for the preparation and use of same |
| 05/31/1995 | EP0655460A1 Pharmacotherapeutical use of glutathione derivatives |
| 05/31/1995 | EP0576420B1 Novel derivative of caffeic acid, oraposide, cosmetic or pharmaceutical, particularly dermatological, composition containing it |
| 05/30/1995 | US5420019 Stable bactericidal/permeability-increasing protein muteins |
| 05/30/1995 | US5419894 Complexing agents, complexes and complex salts |
| 05/17/1995 | EP0652878A1 Pyridoindolobenzodiazepines and derivatives as antipsychotics |
| 05/17/1995 | EP0652871A1 Benzodiazepine derivatives |
| 05/16/1995 | CA1335577C Superoxide dismutase analogs having novel binding properties |
| 05/10/1995 | EP0652010A1 Use of alphatocopherol acetate or a derivative for the preparation of cosmetic, dermatalogical or pharmaceutical compositions with anti radical activity |
| 05/10/1995 | EP0651609A1 Pasteurella multocida toxoid vaccines |
| 05/04/1995 | WO1995011894A1 Histamine h3-receptor antagonists and therapeutic uses thereof |
| 05/04/1995 | WO1995011885A1 Certain fused pyrrolecarboxanilides; a new class of gaba brain receptor ligands |
| 05/04/1995 | WO1995011690A1 Desferrioxamine oral delivery system |
| 05/03/1995 | EP0651055A2 Uses of modified cholinesterase and compositions containing them |
| 05/03/1995 | EP0327612B1 Pharmaceutical therapeutic use of glutathione derivatives |
| 05/02/1995 | CA1335450C Indole and indazole keto sulphones as leukotriene antagonists |
| 04/27/1995 | WO1995011236A1 New chemopreventive compounds and a preparation method and use thereof |
| 04/25/1995 | US5409935 Xanthine derivatives for the treatment of secondary nerve cell damage and functional disorders after cranio-cerebral traumas |
| 04/20/1995 | WO1995010506A1 1n-alkyl-n-arylpyrimidinamines and derivatives thereof |
| 04/13/1995 | WO1995009848A2 Polyazacycloalkanes as dichelants |
| 04/13/1995 | CA2172735A1 Polyazacycloalkanes as dichelants |
| 04/11/1995 | US5405874 Improving short term memory by administering spin-trapping agents such as N-tert-butyl-alpha-phenylnitrone, 5,5-dimethyl-1-pyrroline N-oxide or alpha-/4-pyridyl 1-oxide/-N-tert-butylnitrone |
| 04/04/1995 | US5403834 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 03/23/1995 | WO1995007700A1 Method for protection against genotoxic mutagenesis |
| 03/22/1995 | EP0428636B1 Use of interleukin 2 to treat endotoxinemia |
| 03/22/1995 | EP0301087B1 Peptide |
| 03/22/1995 | CN1100424A Pyridoindolobenzodiazepines and derivatives as antipsychotics |
| 03/16/1995 | WO1995007270A1 Chelants as contrast enhancing agents |
| 03/15/1995 | EP0642507A1 Catalytic antibodies against cocaine and methods of using and producing same |
| 03/15/1995 | EP0433393B1 Treatment of damaged bone marrow and dosage units therefor |
| 02/21/1995 | US5391328 Apparatus for introducing and bonding gas into water |
| 02/15/1995 | EP0637959A1 Soluble analogs of probucol |
| 02/15/1995 | CN1098624A Pharmaceutical preparation containing L-aspartate or L-asparagine for preventing ethanol toxicity, and process for preparation thereof |
| 02/14/1995 | US5389359 Pharmaceutical preparation containing L-aspartate or L-asparagine for preventing ethanol toxicity, and process for preparation thereof |
| 02/08/1995 | EP0637203A1 Regulation of the immune system |
| 02/07/1995 | US5387579 Use of α-tocopherol phosphate or a derivative thereof for preparing cosmetic, dermatological or pharmaceutical compositions, and compositions thereby obtained |
| 02/02/1995 | WO1995003322A1 Nickel-free hemoglobin and methods for producing such hemoglobin |
| 02/02/1995 | WO1995003304A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 02/02/1995 | WO1995003285A1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists |
| 02/02/1995 | CA2167308A1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists |
| 02/02/1995 | CA2166616A1 Nickel-free hemoglobin and methods for producing such hemoglobin |
| 01/26/1995 | WO1995002591A1 Tri-substituted imidazoles having multiple therapeutic properties |
| 01/26/1995 | CA2167311A1 Tri-substituted imidazoles having multiple therapeutic properties |
| 01/25/1995 | EP0635265A1 Controlled release pharmaceutical compositions based on one or more pharmaceutically acceptable salts of gamma hydroxy-butyric acid |
| 01/25/1995 | EP0576619B1 1,2-dithiole-3-thione derivative-based therapeutical compositions |
| 01/25/1995 | CN1097616A Cosmetics or pharmaceutical composition prepared from polyphenol and material obtained from ginkgo |
| 01/18/1995 | EP0634392A2 Esters of acyl L-carnitines and pharmaceutical compositions containing same for treating endotoxic shock |
| 01/18/1995 | EP0633882A1 4- 4'-piperidinyl or 3'-pirrolidinyl] substituted imidazoles as h3-receptor antagonists and therapeutic uses thereof |
| 01/04/1995 | EP0631778A1 Use of L-aspartate or L-asparagine to prevent alcohol toxicity |
| 12/20/1994 | CA1333647C Heptapeptide analogs of somatostatin |
| 12/14/1994 | EP0627928A1 Use of muramyl peptide for the treatment of toxicity |
| 12/14/1994 | EP0627909A1 Cosmetic or pharmaceutical composition containing a combination of a polyphenol and a ginkgo extract |
| 12/08/1994 | WO1994027621A1 Iron-binding polymers for oral administration |
| 12/06/1994 | US5371186 Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock |
| 11/30/1994 | CN1095620A Toxin-reducing health-care liquor and its prodn. technique |
| 11/24/1994 | WO1994026296A1 Novel opioid peptide inhibitors |
| 11/24/1994 | CA2163020A1 Novel opioid peptide inhibitors |
| 11/23/1994 | CN1095268A Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 11/22/1994 | US5367053 Opioid peptide inhibitors |
| 11/15/1994 | US5364613 Polychelants containing macrocyclic chelant moieties |
| 11/10/1994 | WO1994025052A1 Use of glutathione diesters |
| 11/09/1994 | EP0623144A1 Synthetic peptides for detoxification of bacterial endotoxins and treatment of septic shock |
| 11/08/1994 | US5362733 Lipid peroxidation prevention |
| 11/02/1994 | EP0603412A4 Compounds based on palladium and on derivatives of aromatic amines and method of obtaining them. |
| 10/27/1994 | WO1994024285A1 Macrophage inflammatory protein variants |
| 10/26/1994 | EP0620741A1 Cytotoxic drug therapy |
| 10/19/1994 | EP0619808A1 3-hydroxypyridin-4-one derivatives as chelating agents |
| 10/19/1994 | CN1093706A Crystalline salts of optically active aminocoumaran derivaticves, their production and use |
| 10/18/1994 | CA1332604C Carbocyclic compounds |
| 10/18/1994 | CA1332566C Agent containing aminobenzoic acid derivative as an active ingredient having an activity to reduce side effects induced by an administration of immuno-suppressant |
| 10/13/1994 | WO1994022858A1 Tetracyclic compounds as dopamine agonists |
| 10/12/1994 | CN1093363A Substituted pyrazoles |
| 10/05/1994 | EP0617958A1 Pharmaceutical composition having anti-alcohol, radioprotecting and anti-choleraic activity and stimulating energy metabolism, stomach mucous membrane acid-generation and secretion functions |
| 10/05/1994 | CN1092980A Crystalline amifostine compositions and mthods for the preparation and use of same |
| 09/21/1994 | EP0481013B1 A composition for removing or inactivating harmful components in blood or other extracellular body fluids |
| 09/14/1994 | EP0614663A1 Pharmaceutical composition containing a general anaesthetic and selegiline |
| 09/13/1994 | US5346697 Active oxygen scavenger |
| 09/10/1994 | CA2118560A1 Anaesthetic pharmaceutical composition comprising a general anaesthetic and selegiline |
| 09/06/1994 | US5344822 Methods useful in endotoxin prophylaxis and therapy |
| 08/31/1994 | EP0496796B1 Method and compositions for inhibition of disorders associated with oxidative damage |
| 08/31/1994 | EP0408691B1 Antinephrotoxic perfusion solution |
| 08/18/1994 | WO1994018323A1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 08/16/1994 | CA1331458C Paramagnetic compounds |
| 08/09/1994 | US5336675 Administering acetylcholinesterase inhibitor which can pass through blood-brain barrier in humans |
| 07/27/1994 | EP0607222A1 Dendrimeric polychelants |
| 07/27/1994 | EP0486632B1 Anti-actinic agent |
| 07/21/1994 | WO1994015641A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof |
| 07/21/1994 | WO1994015600A1 Application of riluzole as a radiorestorer |
| 07/21/1994 | CA2153776A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof |
| 07/20/1994 | EP0606366A1 Substituted phenserines and phenylcarbamates of (-)-eseroline, (-)-n1-noreseroline, and (-)-n1-benzylnoreseroline; as specific inhibitors of acetylcholinesterase |
| 07/19/1994 | US5330975 Bacterial toxin neutralizer |
| 07/12/1994 | US5328992 Metal complexes of polyethylene glycol carbamate derivatives of desferrioxamine B |
| 07/12/1994 | US5328912 Certain azacycloalkyl imidazopyrimidines; a new class of GABA brain receptor ligands |
| 07/07/1994 | WO1994014414A1 Cosmetic or pharmaceutical composition containing a combination of a polyphenol and a ginkgo extract |
| 07/07/1994 | CA2130449A1 Cosmetic or pharmaceutical composition containing a polyphenol and a ginkgo extract |
| 06/29/1994 | EP0603412A1 Compounds based on palladium and on derivatives of aromatic amines and method of obtaining them |
| 06/23/1994 | WO1994013687A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |